Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Cash & Equivalents (2021 - 2025)

OneMedNet has reported Cash & Equivalents over the past 5 years, most recently at $541000.0 for Q4 2025.

  • Quarterly Cash & Equivalents rose 214.53% to $541000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $541000.0 through Dec 2025, up 214.53% year-over-year, with the annual reading at $541000.0 for FY2025, 214.53% up from the prior year.
  • Cash & Equivalents was $541000.0 for Q4 2025 at OneMedNet, down from $600000.0 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $2.2 million in Q3 2024 and troughed at $1537.0 in Q3 2023.
  • The 5-year median for Cash & Equivalents is $252961.5 (2022), against an average of $425577.9.
  • Year-over-year, Cash & Equivalents tumbled 99.35% in 2023 and then surged 140173.26% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $453151.0 in 2021, then crashed by 40.2% to $271000.0 in 2022, then plummeted by 82.66% to $47000.0 in 2023, then soared by 265.96% to $172000.0 in 2024, then surged by 214.53% to $541000.0 in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Cash & Equivalents are $541000.0 (Q4 2025), $600000.0 (Q3 2025), and $100000.0 (Q2 2025).